Holen Sie sich die Stockscreener-App
2.86
0.35%
0.010
Handel nachbörslich:
2.86
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt AVXL?
Forum
Prognose
Aktiensplit
Anavex Life Sciences Corp Aktie (AVXL) Neueste Nachrichten
Anavex Life Sciences (AVXL) Board Shakeup Sparks Pre-Market Inte - GuruFocus
Anavex gains as PVG calls for board reshuffle (AVXL:NASDAQ) - Seeking Alpha
ANAVEX LIFE SCIENCES CORP. SEC Filing (Sep 3, 2026) - Stock Titan
PVG Asset Management Pushes for Board Changes at Anavex Life Sci - GuruFocus
PVG Asset Management targets Anavex (NASDAQ: AVXL) board in 2026 vote push - Stock Titan
Anavex Life Sciences Regains Nasdaq Compliance After Filing Quarterly Reports - marketscreener.com
Anavex Life Sciences regains Nasdaq compliance By Investing.com - Investing.com Nigeria
Anavex Life Sciences regains Nasdaq compliance after filing delayed 10-Qs - TradingView
Anavex Life Sciences regains Nasdaq compliance - Investing.com India
Anavex Life Sciences Regains Compliance with Nasdaq Periodic Filing Requirement - Anavex Life Sciences
Anavex will keep trading on Nasdaq after filing its outstanding reports - Stock Titan
AVXL Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
New proxy contest hits Anavex (AVXL) as PVG presses its case for the 2026 shareholder vote - Stock Titan
PVG Asset Management Corporation Files Definitive Proxy Statement and Launches Shareholder Website in Connection with Anavex Life Sciences Corp.’s 2026 Annual Meeting - The Manila Times
PVG Asset Management Corporation Files Definitive Proxy - GlobeNewswire
Anavex Life Sciences : Amendment to Annual Report (Form 10-K/A) - marketscreener.com
Anavex (AVXL) admits control weakness yet keeps Dec. 2025 numbers - Stock Titan
Anavex: After The EU Said No, The FDA Path Looks Long And Expensive - Seeking Alpha
Anavex Life Sciences Releases Q3 2026 Financial Results - AlphaStreet
Anavex Life Sciences reports Q3 FY2026 net income $7.8M, cash $118.3M - TradingView
Anavex Life Sciences: Fiscal Q3 Earnings Snapshot - KING5.com
Anavex Life Sciences (AVXL) Sees Stock Surge Following Q3 Update and Regulatory Progress - GuruFocus
Anavex (AVXL) Momentum: Moves 7.67% Down to $3.13; Technical Setup: the $2.97 to $3.29 Range Remains in Focus on the DayRetail Volume - Vinanet
PVG mounts six-seat board challenge at Anavex (AVXL) - Stock Titan
Anavex Life Sciences Corp (AVXL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Anavex Life Sciences Releases Stockholder Letter and Press Release for 2026 Annual Meeting - Kalkine Media
Anavex Urges Shareholders to Back Six Director Nominees Ahead of 2026 Annual Meeting - Yahoo Finance
Form 8K Anavex Life Sciences Corp For: 17 August By Investing.com - Investing.com Canada
Anavex Life Sciences Mails Letter to Stockholders Reinforcing Relevant Experience of All Six Director Nominees - The Manila Times
Six Anavex Director Nominees Face a Sept. 24 Vote—What Sets Them Apart? - Stock Titan
Promising Penny Stocks To Consider In August 2026 - Sahm
(AVXL) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Anavex Life Sciences Files Proxy, Urges Director Support - The Globe and Mail
Anavex Life Sciences Corp. (NASDAQ:AVXL) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Anavex urges shareholders to back board slate amid proxy fight By Investing.com - Investing.com UK
Anavex Life Sciences files definitive proxy, urges vote for six director nominees ahead of Sept. 24 meeting - TradingView
Anavex Life Sciences Faces September Board Vote as Blarcamesine Regulatory Strategy Advances - Yahoo Finance
Anavex urges shareholders to back board slate amid proxy fight - Investing.com
Anavex Life Sciences Highlights Highly Qualified Board and Decisive Actions to Create Long-Term Value for Stockholders - The Manila Times
Anavex Life Sciences Files Definitive Proxy Statement and Urges Stockholders to Vote for All Six Director Nominees on WHITE Card - Quiver Quantitative
Anavex Life Sciences Corp Solicits Proxies from Shareholders - marketscreener.com
Anavex Life Sciences (NASDAQ:AVXL) Stock Crosses Above 50-Day Moving AverageWhat's Next? - MarketBeat
Anavex Life Sciences (NASDAQ: AVXL) delays two 2026 quarterly SEC reports - Stock Titan
AVXL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Anavex Life Sciences Corp expected to post a loss of 8 cents a shareEarnings Preview - TradingView
Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a Potential 509% Upside in Biotech - DirectorsTalk Interviews
Anavex Life Sciences Corp. Revenue Breakdown – NASDAQ:AVXL - TradingView
Anavex Life Sciences (NASDAQ:AVXL) Rallies Today on clinical-stage momentum - Kalkine Media
Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation - anavex.com
Press Release: Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation - moomoo.com
Weekly Recap: IND filing for blarcamesine and Q2 loss, cash runway - TradingView
[PREC14A] ANAVEX LIFE SCIENCES CORP. Preliminary Contested Proxy Statement - Stock Titan
Vanguard Capital Management (NASDAQ: AVXL) discloses 5.03% beneficial stake in Anavex - Stock Titan
Anavex Life Sciences: Fiscal Q2 Earnings Snapshot - KING5.com
Anavex expects $127M cash to fund operations into 2028 - Stock Titan
Second Circuit Holds that Delayed, Market-Tracking Stock Drop Dooms Loss Causation - Jones Day
Anavex Life Sciences Corp (AVXL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Anavex Life Sciences Corp (AVXL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Anavex Life Sciences Corp (AVXL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
0.86%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):